Neovascular age-related macular degeneration Trials in Palm Desert, United States

Neovascular age-related macular degeneration is a medical condition with active clinical research programs worldwide.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT04516278	A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders	COMPLETED	PHASE3
NCT02530918	Study of DS-7080a for the Treatment of Macular Degeneration	COMPLETED	PHASE1
NCT03834753	A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)	COMPLETED	PHASE3
NCT03577899	Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)	TERMINATED	PHASE3
NCT03345082	A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD	COMPLETED	PHASE2
NCT00964795	Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular (Wet) Age-related Macular Degeneration (AMD)	COMPLETED	PHASE3
NCT05904028	Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD	RECRUITING	PHASE3
NCT04757610	OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)	TERMINATED	PHASE3
NCT04777201	A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration	COMPLETED	PHASE3
NCT02713204	Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection	COMPLETED	PHASE2